Dr. Delphine Guyon-Gellin, DVM

Delphine has 15 years experience in vaccines business and strategy working as strategic consultant for leading pharmaceutical companies to help them solve their key challenges, along with an in-depth expertise in strategy for vaccines Prior experience: • Project leader, Boston Consulting Group, London (2014-2017) • Senior Consultant, Boston Consulting Group, Paris (2011-2014) • Junior Consultant, …

Dr Nicola Groth, MD

Nicola has 25 years of experience in vaccine development with considerable expertise in influenza vaccines. Through her various strategic positions in the industry, she has developed expertise throughout the vaccine lifecycle, including close and extensive interactions with regulatory agencies. Prior Experience: • Global Head of Safety Evaluation & Risk Management, GlaxoSmithKline (GSK) Vaccines, Siena (2015-2023) …

Dr Florence Nicolas, PhD

Florence has more than 25 years of experience in the development of biological products, vaccines and delivery systems, in particular in the areas of CMC, pharmacology, preclinical studies and preparation of regulatory documents for clinical trial application. Florence is also the Head of the influenza vaccine program. She also holds extensive experience in project and …

Alexandre Le Vert

Alexandre has more than 20 years of experience in healthcare ranging from research and development to commercialization of vaccines and therapeutics He is an experienced entrepreneur in biotech and innovation Alexandre is a Board Member of several biotech companies in France and in the US Prior experience: • CEO, IMAXIO (2011-2017) • Investment Director, Pradeyrol …

Prof. Arnold Monto

Prof. Arnold S. Monto, MD is Professor Emeritus of Epidemiology and Global Public Health at the University of Michigan School of Public Health, where he also serves as Co-Director of the Michigan Center for Respiratory Virus Research and Response. He is an internationally recognized expert in influenza, respiratory virus epidemiology, vaccine effectiveness, pandemic preparedness and …